Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion – In Vitro Functional and Molecular Studies
Ilona Gurgul, Ewelina Janczy-Cempa, Olga Mazuryk, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10459-10470
Open Access | Times Cited: 17

Showing 17 citing articles:

Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
Maria Grazia Ferraro, Marco Bocchetti, Claudia Riccardi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6473-6473
Open Access | Times Cited: 17
Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2-N-(2-quinolylmethylene)aminophenol
Shuangshuang Gai, Liqin He, Mingxian He, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4876-4876
Open Access | Times Cited: 14
Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections
Assunta D’Amato, Annaluisa Mariconda, Domenico Iacopetta, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1729-1729
Open Access | Times Cited: 14
Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells
Huiyan Hu, Huiwen Zhang, Ruitong Zhong, et al.
Journal of Inorganic Biochemistry (2023) Vol. 244, pp. 112230-112230
Closed Access | Times Cited: 12
Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple-negative breast cancer
Xueyu Man, Minghui Zhu, Shanhe Li, et al.
Rare Metals (2025)
Closed Access
On-site delivery of bioactive nanospheres utilizing lanthanides as crosslinkers and metastasis-inhibiting agents for breast cancer therapy
Yu‐Chi Wang, Yan-Ting Lin, P. S. Hsieh, et al.
Journal of Controlled Release (2025), pp. 113671-113671
Closed Access
Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling
Larissa M. Bomfim, Sara P. Neves, Amanda M. R. M. Coelho, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone
Luciano de S. Santos, Valdenizia R. Silva, Maria V. L. de Castro, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 7
Enhancement of the Cytotoxicity of Quinazolinone Schiff Base Derivatives with Copper Coordination
Ilona Gurgul, Jana Hricovíniová, Olga Mazuryk, et al.
Inorganics (2023) Vol. 11, Iss. 10, pp. 391-391
Open Access | Times Cited: 6
Recent Trends on the Design and Delivery Strategies of Ruthenium Complexes for Breast Cancer Therapy
Utpal Das, Uttara Basu, Priyankar Paira
Dalton Transactions (2024) Vol. 53, Iss. 36, pp. 15113-15157
Closed Access | Times Cited: 2
Ruthenium complex containing 1,3-thiazolidine-2-thione inhibits hepatic cancer stem cells by suppressing Akt/mTOR signalling and leading to apoptotic and autophagic cell death
Sara P. Neves, Larissa M. Bomfim, Tetsushi Kataura, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117059-117059
Open Access | Times Cited: 1
Four new ruthenium(II) coordination compounds bearing coumarin derivatives as anticancer agents
Qi‐Pin Qin, Xiaofeng Zhou, Ling-Qi Du, et al.
Polyhedron (2024) Vol. 263, pp. 117192-117192
Closed Access | Times Cited: 1
Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation
Orsolya Dömötör, Ricardo G. Teixeira, Gabriella Spengler, et al.
Journal of Inorganic Biochemistry (2022) Vol. 238, pp. 112058-112058
Closed Access | Times Cited: 6
Ruthenium(II) complexes as mitochondrial inhibitors of topoisomerase induced A549 cell apoptosis
Hong Tang, Xinhua Guo, Wenzhu Yu, et al.
Journal of Inorganic Biochemistry (2023) Vol. 246, pp. 112295-112295
Closed Access | Times Cited: 3
Exploration of the Pharmacophore for Cytoskeletal Targeting Ruthenium Polypyridyl Complexes
Melissa M. Reardon, Matthew Guerrero, Nagham Alatrash, et al.
ChemMedChem (2023) Vol. 18, Iss. 21
Closed Access | Times Cited: 1
Insight into Structure-Activity Relationship of New Compounds for Breast Cancer Treatment
Lu Li, Qiangsheng Zhang
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 25, pp. 2373-2393
Closed Access | Times Cited: 1
Impact of Polypyridyl Ru Complexes on Angiogenesis—Contribution to Their Antimetastatic Activity
Ilona Gurgul, Olga Mazuryk, Kamila Stachyra, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7708-7708
Open Access | Times Cited: 2
Page 1

Scroll to top